Interleukin-12-induced adhesion molecule expression in murine liver

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 457-468

  Myers, Kathleen J ^a,d   Eppihimer, Michael J ^c   Hall, LeRoy ^b   Wolitzky, Barry ^a  

^a HOFFMANN LA ROCHE INC   (United States)

^b Hoffmann La Roche Department of Toxicology and Pathology   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA1 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PADGEM PROTEIN; RECOMBINANT INTERLEUKIN 12; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-12; LEUKOCYTES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; SELECTINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031907168     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 1992, 143:127-142
2. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991, 147:874-882
3. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF). Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992, 175:779-788
4. h cells. J Exp Med 1993, 177:1199-1204
5. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549
6. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 1989, 170:827-845
7. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cell and synergy with other inducers. J Exp Med 1991, 173:869-879
8. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-γ. J Immunol 1994, 152:1883-1887
9. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR: IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995, 155:2515-2524
10. Schijns VE, Haagmans BL, Horzinek MC: IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J Immunol 1995, 155:2525-2532
11. Orange JS, Wang B, Terhorst C, Biron CA: Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995, 182:1045-1056
12. Bi Z, Quandt P, Komatsu T, Barna M, Reiss CS: IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J Immunol 1995, 155:5684-5689
13. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993, 177:1797-1802
14. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993, 90:6115-6119
15. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993, 177:1505-1509
16. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A: Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994, 179:1551-1561
17. Khan IA, Matsuura T, Kasper LH: Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 1994, 62:1639-1642
18. Clemons KV, Brummer E, Stevens DA: Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994, 38:460-464
19. Sedegah M, Finkelman F, Hoffman SL: Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc Natl Acad Sci USA 1994, 91:10700-10702
20. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK: Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993, 178:1223-1230
21. O'Toole M, Wolf SF, O'Brien C, Hubbard B, Herrmann S: Effect of in vivo IL-12 administration on murine tumor cell growth. J Immunol 1993, 150:294A
22. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ: Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 1994, 153:1697-1706
23. Gately MK, Gubler U, Brunda MJ, Nadeau RR, Anderson TD, Lipman JM, Sarmiento U: Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases. Ther Immunol 1994, 1:187-194
24. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR, Murphy M: Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 1994, 6:157-167
25. Sarmiento UM, Riley JH, Knaack PA, Lipman JM, Becker JM, Gately MK, Chizzonite R, Anderson TD: Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab Invest 1994, 71:862-873
26. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991, 67:1033-1036
27. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314
28. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in infalmmation: distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA 1991, 88:7538-7542
29. Lasky LA: Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992, 258:964-969
30. Ley K: Molecular mechanisms of leukocyte rolling and adhesion to microvascular endothelium. Eur Heart J 1993, 14:68-73
31. Zimmerman GA, Prescott SM, McIntyre TM: Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992, 13:93-99
32. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101
33. Albelda SM, Smith CW, Ward PA: Adhesion molecules and inflammatory injury. FASEB J 1994, 8:504-512
34. Albelda SM, Buck CA: Integrins and other cell adhesion molecules. FASEB J 1990, 4:2868-2880
35. Elices MJ: Leukocyte Integrins. Integrins. Edited by Cheresh DA, Mecham RP. San Diego, Academic Press, 1994, pp 163-194
36. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990, 60:577-584
37. Diamond MS, Springer TA: The dynamic regulation of integrin adhesiveness. Curr Biol 1994, 4:506-517
38. Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA, Granger DN: Heterogeneity of expression of E-and P-selectin in vivo. Circ Res 1996, 79:560-569
39. Henninger DD, Panes J, Russell J, Gerritsen M, Anderson DC, Granger DN: Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997, 158:1825-1832
40. Panes J, Perry MA, Anderson DC, Manning A, Leone B, Cepinskas G, Rosenbloom CL, Miyasaka M, Kvietys PR, Granger DN: Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 1995, 269:H1955-H1964
41. Ledbetter JA, Herzenberg LA: Xeongenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979, 47: 63-90
42. Scheid M, Triglia D: Further specificity of the Ly-5 system. Immunogen 1979, 9:423-433
43. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL, Keller JR: Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991, 147:22-28
44. Jung TM, Gallatin WM, Weissman IL, Dailey MO: Down-regulation of homing receptors after T cell activation. J Immunol 1988, 141:4110-4117
45. Kishimoto TK, Jutila MA, Berg EL, Butcher EC: Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors Science 1989, 245:1238-1241
46. Lee S, Starkey PM, Gordon S: Quantitative analysis of total macrophage content in adult mouse tissues. J Exp Med 1985, 161:475-489
47. + cells in the liver of mice. J Exp Med 1994, 180:699-704
48. + T cells are present within a population of intermediate TCR cells. J Immunol 1995, 155:2972-2983
49. + α/β T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995, 154:4333-4340
50. Seki S, Abo T, Ohteki T, Sugiura K, Kumagai K: Unusual α/β-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver. J Immunol 1991, 147:1214-1221
51. + α/β T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996, 156:2436-2442
52. Blanchi G, Sironi M, Ghibaudi E, Selvaggini C, Elices M, Allavena P, Mantovani A: Migration of natural killer cells across endothelial cell monolayers. J Immunol 1993, 151:5135-5144
53. Maenpäa A, Jäaskelainen J, Carpën O, Patarroyo M, Timonen T: Expression of integrins and other adhesion molecules on NK cells: impact of IL-2 on short-and long-term cultures. Int J Cancer 1993, 53:850-855
54. Steinhoff G, Behrend M, Schrader B, Pichlmayr R: Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology 1993, 18:440-453
55. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K: Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia: lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3. Am J Pathol 1993, 142:481-488
56. Groves RW, Ross EL, Barker JN, MacDonald DM: Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon γ. J Am Acad Dermatol 1993, 29:67-72
57. Bereta M, Bereta J, Georgoff I, Coffman FD, Cohen S, Cohen MC: Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells. Exp Cell Res 1994, 212:230-242
58. Orange JS, Wolf SF, Biron CA: Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994, 152: 1253-1264
59. + NK cells. J Immunol 1992, 148:2429-2436
60. + T lymphocytes, and NK cells. J Immunol 1992, 149:3495-3502
61. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986, 137:1893-1896
62. Rice GE, Munro JM, Bevilacqua MP: Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/CD18-independent adhesion mechanism. J Exp Med 1990, 171:1369-1374
63. Car BD, Eng VM, Schnyder B, LeHir M, Shakhov AN, Woerly G, Huang S, Aguet M, Anderson TD, Ryffel B: Role of interferon-γ in interleukin 12-induced pathology in mice. Am J Pathol 1995, 147: 693-1707
64. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995, 182:1281-1290
65. Leonard JP, Waldburger KE, Goldman SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 1995, 181:381-386
66. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L: Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181: 817-821
67. Williamson E, Garside P, Bradley JA, Mowat AM: IL-12 is a central mediator of acute graft-versus-host disease in mice. J Immunol 1996, 157:689-699
68. Neta R, Stiefel SM, Finkelman F, Herrmann S, Ali N: IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation J Immunol 1994, 153:4230-4237
69. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson CG, Reichert CM: Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant IL-2 to patients with metastatic cancer. N Engl J Med 1985, 313: 1485-1492
70. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987, 316: 889-897
71. Neumann B, Machleidt T, Lifka A, Reffer K, Vestweber D, Mak TW, Holzmann B, Kronke M: Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 1996, 156:1587-1593
72. Smith JW, Urba WJ, Curti BD, Elwood LJ, Steis RG, Janik JE, Sharfman WH, Miller LL, Fenton RG, Conlon KC: The toxic and hematologic effects of interleukin-1α administered in a phase I trial to patients with advanced malignancies. J Clin Oncol 1992, 10:1141-1152
73. + T cells. Eur J Immunol 1995, 25:3053-3059
74. Kuhn R, Lohler D, Rennick D, Rajewsky K, Muller W: Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274